These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 7956218)
1. Prolactin injection, a new contraceptive method: experimental study. Shafik A Contraception; 1994 Aug; 50(2):191-9. PubMed ID: 7956218 [TBL] [Abstract][Full Text] [Related]
2. Contraceptive efficacy of polyester-induced azoospermia in normal men. Shafik A Contraception; 1992 May; 45(5):439-51. PubMed ID: 1623716 [TBL] [Abstract][Full Text] [Related]
3. Suppression of human spermatogenesis by testosterone implants. Handelsman DJ; Conway AJ; Boylan LM J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094 [TBL] [Abstract][Full Text] [Related]
4. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869 [TBL] [Abstract][Full Text] [Related]
5. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300 [TBL] [Abstract][Full Text] [Related]
6. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. Behre HM; Nashan D; Hubert W; Nieschlag E J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833 [TBL] [Abstract][Full Text] [Related]
7. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. Wallace EM; Gow SM; Wu FC J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955 [TBL] [Abstract][Full Text] [Related]
8. Testicular suspension as a method of male contraception: technique and results. Shafik A Adv Contracept Deliv Syst; 1991; 7(3-4):269-79. PubMed ID: 12284770 [TBL] [Abstract][Full Text] [Related]
9. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. Anderson RA; Wallace AM; Wu FC J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548 [TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive. Bremner WJ; Bagatell CJ; Steiner RA J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925 [TBL] [Abstract][Full Text] [Related]
11. Antispermatogenic effects of tolnidamine in langur (Presbytis entellus). Lohiya NK; Ansari AS; Scorza Barcellona P Contraception; 1991 May; 43(5):485-96. PubMed ID: 1914461 [TBL] [Abstract][Full Text] [Related]
12. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility Fertil Steril; 1996 Apr; 65(4):821-9. PubMed ID: 8654646 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats. Huynh PN; Hikim AP; Wang C; Stefonovic K; Lue YH; Leung A; Atienza V; Baravarian S; Reutrakul V; Swerdloff RS J Androl; 2000; 21(5):689-99. PubMed ID: 10975416 [TBL] [Abstract][Full Text] [Related]
14. Investigations on the use of testosterone oenanthate as a male contraceptive agent. Mauss J; Börsch G; Richter E; Bormacher K Contraception; 1974 Sep; 10(3):281-9. PubMed ID: 4374338 [TBL] [Abstract][Full Text] [Related]
15. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948 [TBL] [Abstract][Full Text] [Related]
16. The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels. Frick J; Bartsch G; Weiske WH Contraception; 1977 Jun; 15(6):649-68. PubMed ID: 891192 [TBL] [Abstract][Full Text] [Related]
17. Suppression of spermatogenesis by testosterone enanthate in Thai men. Aribarg A; Sukcharoen N; Chanprasit Y; Ngeamvijawat J; Kriangsinyos R J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996 [TBL] [Abstract][Full Text] [Related]
18. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment. Soufir JC; Jouannet P; Marson J; Soumah A Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496 [TBL] [Abstract][Full Text] [Related]
19. Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men. Moltz L; Römmler A; Post K; Schwartz U; Hammerstein J Contraception; 1980 Apr; 21(4):393-413. PubMed ID: 6771095 [TBL] [Abstract][Full Text] [Related]
20. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. Matsumoto AM J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]